Logo image of AXR

AMREP CORP (AXR) Stock Fundamental Analysis

USA - NYSE:AXR - US0321591051 - Common Stock

23.86 USD
-0.06 (-0.25%)
Last: 10/1/2025, 8:24:05 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to AXR. AXR was compared to 64 industry peers in the Real Estate Management & Development industry. AXR has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. AXR scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make AXR a good candidate for value and quality investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

AXR had positive earnings in the past year.
AXR had a positive operating cash flow in the past year.
AXR had positive earnings in each of the past 5 years.
AXR had a positive operating cash flow in each of the past 5 years.
AXR Yearly Net Income VS EBIT VS OCF VS FCFAXR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

1.2 Ratios

With an excellent Return On Assets value of 9.49%, AXR belongs to the best of the industry, outperforming 95.31% of the companies in the same industry.
AXR's Return On Equity of 9.90% is amongst the best of the industry. AXR outperforms 85.94% of its industry peers.
AXR has a Return On Invested Capital of 8.47%. This is amongst the best in the industry. AXR outperforms 95.31% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AXR is in line with the industry average of 6.56%.
The 3 year average ROIC (7.98%) for AXR is below the current ROIC(8.47%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.49%
ROE 9.9%
ROIC 8.47%
ROA(3y)11.25%
ROA(5y)11.62%
ROE(3y)11.7%
ROE(5y)12.51%
ROIC(3y)7.98%
ROIC(5y)10.76%
AXR Yearly ROA, ROE, ROICAXR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

AXR has a better Profit Margin (27.54%) than 92.19% of its industry peers.
AXR's Profit Margin has declined in the last couple of years.
AXR's Operating Margin of 27.37% is amongst the best of the industry. AXR outperforms 89.06% of its industry peers.
AXR's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 42.83%, AXR is in the better half of the industry, outperforming 73.44% of the companies in the same industry.
AXR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 27.37%
PM (TTM) 27.54%
GM 42.83%
OM growth 3Y-12.34%
OM growth 5YN/A
PM growth 3Y-1.77%
PM growth 5YN/A
GM growth 3Y-4.88%
GM growth 5Y19.57%
AXR Yearly Profit, Operating, Gross MarginsAXR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

9

2. Health

2.1 Basic Checks

AXR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AXR has been increased compared to 1 year ago.
AXR has less shares outstanding than it did 5 years ago.
AXR has a better debt/assets ratio than last year.
AXR Yearly Shares OutstandingAXR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
AXR Yearly Total Debt VS Total AssetsAXR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 15.39 indicates that AXR is not in any danger for bankruptcy at the moment.
AXR has a Altman-Z score of 15.39. This is amongst the best in the industry. AXR outperforms 92.19% of its industry peers.
AXR has a debt to FCF ratio of 0.00. This is a very positive value and a sign of high solvency as it would only need 0.00 years to pay back of all of its debts.
AXR has a better Debt to FCF ratio (0.00) than 92.19% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that AXR is not too dependend on debt financing.
AXR's Debt to Equity ratio of 0.00 is amongst the best of the industry. AXR outperforms 87.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 15.39
ROIC/WACC0.94
WACC9.04%
AXR Yearly LT Debt VS Equity VS FCFAXR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 19.25 indicates that AXR has no problem at all paying its short term obligations.
With an excellent Current ratio value of 19.25, AXR belongs to the best of the industry, outperforming 96.88% of the companies in the same industry.
AXR has a Quick Ratio of 8.29. This indicates that AXR is financially healthy and has no problem in meeting its short term obligations.
AXR's Quick ratio of 8.29 is amongst the best of the industry. AXR outperforms 95.31% of its industry peers.
Industry RankSector Rank
Current Ratio 19.25
Quick Ratio 8.29
AXR Yearly Current Assets VS Current LiabilitesAXR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 41.26% over the past year.
AXR shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.33% yearly.
AXR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.47%.
Measured over the past years, AXR shows a very strong growth in Revenue. The Revenue has been growing by 21.46% on average per year.
EPS 1Y (TTM)41.26%
EPS 3Y2.33%
EPS 5YN/A
EPS Q2Q%14.86%
Revenue 1Y (TTM)-19.47%
Revenue growth 3Y-5.51%
Revenue growth 5Y21.46%
Sales Q2Q%-6.5%

3.2 Future

The Earnings Per Share is expected to grow by 2.71% on average over the next years.
The Revenue is expected to grow by 11.91% on average over the next years. This is quite good.
EPS Next Y-4.48%
EPS Next 2Y-9.75%
EPS Next 3Y-2.85%
EPS Next 5Y2.71%
Revenue Next Year12.31%
Revenue Next 2Y10.34%
Revenue Next 3Y9.64%
Revenue Next 5Y11.91%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
AXR Yearly Revenue VS EstimatesAXR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M
AXR Yearly EPS VS EstimatesAXR Yearly EPS VS EstimatesYearly EPS VS Estimates 2026 2027 2028 2029 0.5 1 1.5 2 2.5

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.58, the valuation of AXR can be described as very reasonable.
Based on the Price/Earnings ratio, AXR is valued cheaper than 92.19% of the companies in the same industry.
AXR is valuated cheaply when we compare the Price/Earnings ratio to 27.79, which is the current average of the S&P500 Index.
AXR is valuated correctly with a Price/Forward Earnings ratio of 12.37.
Based on the Price/Forward Earnings ratio, AXR is valued cheaper than 93.75% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of AXR to the average of the S&P500 Index (23.21), we can say AXR is valued slightly cheaper.
Industry RankSector Rank
PE 9.58
Fwd PE 12.37
AXR Price Earnings VS Forward Price EarningsAXR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AXR is valued cheaper than 100.00% of the companies in the same industry.
89.06% of the companies in the same industry are more expensive than AXR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.89
EV/EBITDA 5.77
AXR Per share dataAXR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

AXR has an outstanding profitability rating, which may justify a higher PE ratio.
AXR's earnings are expected to decrease with -2.85% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.75%
EPS Next 3Y-2.85%

0

5. Dividend

5.1 Amount

AXR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMREP CORP

NYSE:AXR (10/1/2025, 8:24:05 PM)

23.86

-0.06 (-0.25%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)09-09 2025-09-09/amc
Earnings (Next)12-11 2025-12-11
Inst Owners45.09%
Inst Owner Change2.07%
Ins Owners45.01%
Ins Owner Change0.84%
Market Cap126.70M
Analysts80
Price Target27.54 (15.42%)
Short Float %0.85%
Short Ratio2.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)46.41%
EPS NY rev (3m)30.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-99.91%
Valuation
Industry RankSector Rank
PE 9.58
Fwd PE 12.37
P/S 2.61
P/FCF 14.89
P/OCF 13.96
P/B 0.94
P/tB 0.94
EV/EBITDA 5.77
EPS(TTM)2.49
EY10.44%
EPS(NY)1.93
Fwd EY8.09%
FCF(TTM)1.6
FCFY6.71%
OCF(TTM)1.71
OCFY7.16%
SpS9.13
BVpS25.37
TBVpS25.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.49%
ROE 9.9%
ROCE 9.84%
ROIC 8.47%
ROICexc 13.29%
ROICexgc 13.34%
OM 27.37%
PM (TTM) 27.54%
GM 42.83%
FCFM 17.56%
ROA(3y)11.25%
ROA(5y)11.62%
ROE(3y)11.7%
ROE(5y)12.51%
ROIC(3y)7.98%
ROIC(5y)10.76%
ROICexc(3y)10.52%
ROICexc(5y)13.87%
ROICexgc(3y)10.56%
ROICexgc(5y)13.9%
ROCE(3y)9.27%
ROCE(5y)12.5%
ROICexcg growth 3Y-24.11%
ROICexcg growth 5YN/A
ROICexc growth 3Y-24.15%
ROICexc growth 5YN/A
OM growth 3Y-12.34%
OM growth 5YN/A
PM growth 3Y-1.77%
PM growth 5YN/A
GM growth 3Y-4.88%
GM growth 5Y19.57%
F-Score5
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 272.25%
Cap/Sales 1.17%
Interest Coverage 250
Cash Conversion 67.38%
Profit Quality 63.75%
Current Ratio 19.25
Quick Ratio 8.29
Altman-Z 15.39
F-Score5
WACC9.04%
ROIC/WACC0.94
Cap/Depr(3y)283.02%
Cap/Depr(5y)282.35%
Cap/Sales(3y)0.78%
Cap/Sales(5y)0.91%
Profit Quality(3y)86%
Profit Quality(5y)103.5%
High Growth Momentum
Growth
EPS 1Y (TTM)41.26%
EPS 3Y2.33%
EPS 5YN/A
EPS Q2Q%14.86%
EPS Next Y-4.48%
EPS Next 2Y-9.75%
EPS Next 3Y-2.85%
EPS Next 5Y2.71%
Revenue 1Y (TTM)-19.47%
Revenue growth 3Y-5.51%
Revenue growth 5Y21.46%
Sales Q2Q%-6.5%
Revenue Next Year12.31%
Revenue Next 2Y10.34%
Revenue Next 3Y9.64%
Revenue Next 5Y11.91%
EBIT growth 1Y25.45%
EBIT growth 3Y-17.16%
EBIT growth 5YN/A
EBIT Next Year17.54%
EBIT Next 3Y-0.55%
EBIT Next 5Y6.19%
FCF growth 1Y7.67%
FCF growth 3Y-12.03%
FCF growth 5Y66.27%
OCF growth 1Y14.11%
OCF growth 3Y-12.86%
OCF growth 5Y67.79%